ロード中...
Molecular Mechanisms and Therapeutics for SCA17
Spinocerebellar ataxia type 17 (SCA17) is caused by polyglutamine (polyQ) expansion in the TATA box-binding protein (TBP), which functions as a general transcription factor. Like other polyQ expansion-mediated diseases, SCA17 is characterized by late-onset and selective neurodegeneration, despite th...
保存先:
| 出版年: | Neurotherapeutics |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985407/ https://ncbi.nlm.nih.gov/pubmed/31317427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-019-00762-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|